A

Translational Model‐Informed Dose Selection for Iruplinalkib, a Selective Oral ALK / ROS1 Tyrosine Kinase Inhibitor

Clinical and Translational Science

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 1

References 1

1 result